6533b7dbfe1ef96bd126fe9e

RESEARCH PRODUCT

Uveítis anterior aguda hipertensiva granulomatosa bilateral como efecto adverso a brimonidina tópica

C.a. Arciniegas-perassoJ.m. Hervás-hernandisF. García-iborAntonio Duch-samperR. Clemente-tomásN Ruíz-del Río

subject

medicine.medical_specialtySubsequent RelapseSide effectbusiness.industryBrimonidineTimololEmergency departmentmedicine.diseaseDermatology03 medical and health sciencesOphthalmology0302 clinical medicine030221 ophthalmology & optometrymedicineAnterior uveitisAdverse effectbusiness030217 neurology & neurosurgeryUveitismedicine.drug

description

Abstract Clinical case The case concerns an 81-year-old woman on treatment with a topical fixed combination of timolol and brimonidine who was diagnosed in the Emergency Department with acute anterior granulomatous hypertensive uveitis. The patient responded favorably to the withdrawal of the eye drops without showing any subsequent relapse. Discussion Uveitis due to brimonidine is a rare adverse effect, but it must be known. Once the diagnosis is suspected, the effective treatment is the withdrawal of brimonidine, with or without the addition of topical corticosteroids to control inflammation depending on the severity of the condition. It is a process with an excellent prognosis.

https://doi.org/10.1016/j.oftal.2018.05.005